To hear about similar clinical trials, please enter your email below

Trial Title: The IMPACT Implementation-Effectiveness Trial

NCT ID: NCT06323707

Condition: Cancer

Study type: Interventional

Study phase: Phase 2

Overall status: Not yet recruiting

Study design:

Allocation: Randomized

Intervention model: Parallel Assignment

Primary purpose: Supportive Care

Masking: Double (Investigator, Outcomes Assessor)

Intervention:

Intervention type: Behavioral
Intervention name: Exercise
Description: Eight sessions of moderate intensity aerobic exercise using recumbent bike within the cancer institution.
Arm group label: Exercise & Self-Management

Intervention type: Behavioral
Intervention name: Self-management e-module
Description: Eight 15 minute self-management e-modules related to exercise and physical activity for cancer survivors.
Arm group label: Exercise & Self-Management
Arm group label: Self-Management Only

Summary: More Canadians are surviving cancer, however, individuals with cancer live with side effects for years after treatments have ended. The physical and psychosocial benefits of regular physical activity (PA) during and after cancer treatment are well established. However, less than 30% of individuals with cancer meet current PA recommendations and PA levels decline significantly during treatment. PA services within the cancer institution to support well-being during treatment are not available for survivors across Ontario. Strategies are needed within cancer centres to close the gap between the evidence and clinical practice. What is the purpose? To evaluate the effectiveness of a novel exercise and education strategy for individuals with cancer during treatment. What are we proposing to do? This project includes two parts. In Part 1 participants will be put into one of three groups. Group 1 (Exercise & self-management) will include eight sessions of supervised, institution-based exercise and self-management education. Group 2 (self-management only) will include eight virtual self-management education sessions with an exercise professional. Group 3 will receive usual care (i.e., no intervention). In Part 2 participants who attended less than 75% of their sessions will be asked to complete an interview on the barriers to continuing with the study during cancer treatment. Why is this work important? Findings from this trial will inform the way PA services are provided within cancer institutions across Ontario. This novel strategy incorporates both institution-based and home-based exercise strategies during treatment and highlights the importance of individuals with cancer taking an active role in managing their condition during treatment. This can prevent future complications and decrease burden on the individual and the healthcare system. Results will inform future decisions on PA implementation strategies for cancer survivors with diverse needs across Ontario.

Detailed description: Rationale: The burden of cancer in Canada is growing. More individuals are surviving cancer, however, individuals with cancer live with side effects for years after treatments have ended. The physical and psychosocial benefits of regular physical activity (PA) during and after cancer treatment are well established. However, less than 30% of individuals with cancer meet current PA recommendations and PA levels decline significantly during active treatment. Institution-based PA services to support wellbeing and minimize burden during treatment are not available across Ontario. Novel implementation strategies are needed within the institution to close the gap between the evidence and clinical practice. Implementation research allows us to understand how to deliver interventions effectively in diverse settings. Aim & Objectives: The overall aim of this project is to conduct a fully powered, multi-centred randomized controlled trial (RCT) to evaluate the effectiveness of a novel implementation strategy including exercise and SM versus usual care for individuals with cancer during treatment. To do this, there are two main objectives: 1) Determine the feasibility and effectiveness of a novel implementation strategy using exercise and SM during treatment Methods: Study Design: Effectiveness-Implementation RCT Participants: Adults (>18 years) with a cancer diagnosis of any stage, currently receiving treatment, and cleared for exercise by their oncology care team will be included in this study. Procedure: Participants will be randomized to three groups. Group 1: Exercise & SM: Eight sessions of supervised, in-person institution-based exercise and SM education. This group will also receive 4 booster sessions by telephone post intervention. Group 2: SM Only: Eight virtual sessions of SM education using video conferencing with a qualified exercise professional. This group will also receive 4 booster sessions by phone post intervention. Group 3: Usual care: No intervention. Significance: Implementation research is crucial to improving our understanding of real-world factors that impact successful application of research in healthcare settings. This novel implementation strategy builds off previous work and incorporates institution-based exercise and SM during treatment. Findings from this trial will build off our previous work and inform the way PA services are provided within cancer institutions across Ontario. Our goal is to make these services available to all individuals with cancer during treatment.

Criteria for eligibility:
Criteria:
Inclusion Criteria: - Community-dwelling - English-speaking adults - Aged over 18 years of age - Currently undergoing adjuvant or neoadjuvant chemotherapy, radiation, or hormonal therapy for cancer - Cleared by their oncologist to participate in moderate intensity aerobic exercise. Exclusion Criteria: - Self-report on the patient intake form any chronic condition, cognitive impairment, or injury that would prevent them from participating independently in moderate intensity exercise

Gender: All

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Start date: March 15, 2024

Completion date: March 15, 2027

Lead sponsor:
Agency: McMaster University
Agency class: Other

Collaborator:
Agency: Canadian Cancer Society (CCS)
Agency class: Other

Collaborator:
Agency: Hamilton Health Sciences Corporation
Agency class: Other

Collaborator:
Agency: Niagara Health System
Agency class: Other

Source: McMaster University

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT06323707

Login to your account

Did you forget your password?